A patent practitioner learns that a client made a material misrepresentation to the USPTO during prosecution. The client refuses to authorize corrective action. What is the practitioner's ethical obligation?
-
A
Continue representation without disclosing the fraud
-
B
Withdraw from representation if the client refuses to correct the fraud
-
C
Inform the USPTO immediately without client consent
-
D
File a continuation to obscure the misrepresentation